Rifampicin-induced fever in a patient with brucellosis: A case report

Thumbnail

View/Open

Access

info:eu-repo/semantics/openAccessAttribution-NonCommercial 4.0 Internationalhttps://creativecommons.org/licenses/by-nc/4.0/

Date

2018

Author

Yılmaz, Mesut
Yaşar, Canan
Aydın, Selda
Derin, Okan
Ceylan, Bahadır
Mert, Ali

Metadata

Show full item record

Citation

Yılmaz, M., Yaşar, C., Aydın, S., Derin, O., Ceylan, B. ve Mert, A. (2018). Rifampicin-induced fever in a patient with brucellosis: A case report. Drug Safety - Case Reports, 5. https://dx.doi.org/10.1007/s40800-018-0074-3

Abstract

We present a 35-year-old female patient who was started on rifampicin (900 mg orally once daily) and trimethoprim/sulfamethoxazole (TMP/SMX) (160/800 mg orally twice daily) after being diagnosed with brucellosis. Following defervescence and improvement in her general condition, fever recurred on the 12th day of treatment. A re-challenge drug test lead to causality assessment and treatment was switched to a combination of streptomycin (1 g intramuscularly) for 10 days and TMP/SMX (160/800 mg orally twice daily) for 4 weeks. Our patient is doing well after 12 months of follow-up.

Source

Drug Safety - Case Reports

Volume

5

URI

https://dx.doi.org/10.1007/s40800-018-0074-3
https://hdl.handle.net/20.500.12511/6404

Collections

info:eu-repo/semantics/openAccess
Except where otherwise noted, this item's license is described as info:eu-repo/semantics/openAccess